PharmaReports: Metabolic & Hormonal Disorders
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
Reports featured here primarily focus on diabetes and obesity. Cachexia is also a focus of this channel as is metabolic dysfunction relating to pharmacological treatment (for example following treatment for HIV infection). Reports relating to hormonal disorders or diseases due to hormonal change (eg osteoporosis) can be featured here.
Showing results 1 - 50 of 115
- The World Market for Prescription Orthopedic Drugs
- Womens Health: Worldwide Prescription Drug Markets
- Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision
- The Protein Therapeutics Market: The Science and Business of a Growing Sector
- Critical Care Pharmaceutical Markets: A Strategic Analysis
- Diabetes and Diabetic Complications: Major World Markets
- Diabetes, Metabolic Syndrome and Cardiovascular Disease
- Women\'s Health: Diagnostic Testing
- Disposable Syringe Markets
- Blood Glucose Testing and Diabetes Management
- Stem Cell Markets
- The Global Endocrine Pharmaceutical Market 2005
- The World Diabetes Market, 2005-2011
- Cannabinoid Market Forecasts & Analysis to 2012
- Pipeline Insight: Dyslipidemia - Pipeline agents unlikely to rejuvenate the market
- Pipeline Insight: Osteoporosis - Intermittent dosing drives market growth
- Early Toxicology: Markets and Approaches
- Atherosclerosis - HDL, ApoA-I, Carotid MRI and 64-slice CT offer opportunities
- Obesity - Lack of Reimbursement Limits Market Potential
- Hormonal Contraceptives - New directions in a competitive market
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Pipeline Insight: Insulins - Inhalable insulins unlikely to become blockbusters
- Antidiabetics - Patent expiries and cost containment initiatives balanced by pipeline products
- Non-insulin Antidiabetics - Type 2 diabetes unlikely to develop into a switch market
- Antidyslipidemics - The Generic Threat
- From Blockbuster to Nichebuster
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Biogenerics
- Metabolic Syndrome - Multiple definitions complicate treatment
- The Global Diabetes Market
- Drug Treatment in End-Stage Renal Disease
- Antidyslipidemics
- Inhalable Drug Delivery
- Therapeutic Vaccines
- Pipeline Insight: Osteoporosis
- Hypertension and Diabetic Kidney Disease - Prevalence, current treatment and future options
- Dyslipidemia - Statins Dominate Treatment Pathway
- Pipeline Insight: Antidyslipidemics
- Commercial Insight: Antidiabetics
- Commercial Insight: Antidyslipidemics
- HRT: Major Milestones - Current Perspectives on HRT and Menopause
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Osteoporosis - Risk management and reformulation offer best defense against generic onslaught
- Drug Discovery Tools for High-Content Analysis
- The Women’s Health Market Outlook to 2011
- Commercial Insight: Antidyslipidemics - The competitive cost-conscious antidyslipidemics market presents challenges
- TYPE 1 DIABETES - Therapy Area Pipeline Report
- DYSLIPIDEMIA - Therapy Area Pipeline Report
- HYPERLIPEMIA - Therapy Area Pipeline Report
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development